Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Possible anti-metastatic effect of Iloprost in a patient with systemic sclerosis with lung cancer: a case study


  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 09 July 2011 - 11:45 AM

Possible anti-metastatic effect of Iloprost in a patient with systemic sclerosis with lung cancer: a case study

Herein, we report iloprost treatment of a 60-year-old-woman with SSc, who lately developed pulmonary hypertension as a complication of her disease and lung adenocarcinoma as a co-incidence simultaneously. Yavuz Pehlivan, Reheumatology International, 30 March 2011 (Also see: Iloprost and Cancer)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)